https://yoda.yale.edu/clinical-trial/nct03162796-a-phase-3-multicenter-randomized-double-blind-placebo-controlled-study-evaluating-the-efficacy-and-safety-of-guselkumab-administered-subcutaneously-in-subjects-with-active-psoriatic/
NCT03162796 - A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating...